Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R
Adv Ecol Res. 2024; 57:201-281.
PMID: 39404686
PMC: 7616576.
DOI: 10.1016/bs.aecr.2016.11.002.
Marshall-Jones Z, Patel K, Castillo-Fernandez J, Lonsdale Z, Haydock R, Staunton R
Sci Rep. 2024; 14(1):5277.
PMID: 38438389
PMC: 10912219.
DOI: 10.1038/s41598-024-51338-7.
Uppal G, Vural D
Biophys J. 2024; 123(3):407-419.
PMID: 38204167
PMC: 10870175.
DOI: 10.1016/j.bpj.2024.01.007.
de Nies L, Kobras C, Stracy M
Nat Rev Microbiol. 2023; 21(12):789-804.
PMID: 37542123
DOI: 10.1038/s41579-023-00936-9.
Agostini D, Gervasi M, Ferrini F, Bartolacci A, Stranieri A, Piccoli G
Nutrients. 2023; 15(8).
PMID: 37111021
PMC: 10141535.
DOI: 10.3390/nu15081802.
Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing.
Xiao G, Cai Z, Guo Q, Ye T, Tang Y, Guan P
Microbiol Spectr. 2022; 10(1):e0190121.
PMID: 35196800
PMC: 8865484.
DOI: 10.1128/spectrum.01901-21.
Clostridioides difficile infection and One Health: an equine perspective.
Hain-Saunders N, Knight D, Bruce M, Riley T
Environ Microbiol. 2022; 24(3):985-997.
PMID: 35001483
PMC: 9304292.
DOI: 10.1111/1462-2920.15898.
Engineering temporal dynamics in microbial communities.
Ronda C, Wang H
Curr Opin Microbiol. 2021; 65:47-55.
PMID: 34739926
PMC: 10659046.
DOI: 10.1016/j.mib.2021.10.009.
Metagenomic Analysis of Fecal Archaea, Bacteria, Eukaryota, and Virus in Przewalski's Horses Following Anthelmintic Treatment.
Hu D, Yang J, Qi Y, Li B, Li K, Mok K
Front Vet Sci. 2021; 8:708512.
PMID: 34490397
PMC: 8416479.
DOI: 10.3389/fvets.2021.708512.
Changes in the Fecal Microbiota Associated with a Broad-Spectrum Antimicrobial Administration in Hospitalized Neonatal Foals with Probiotics Supplementation.
Freccero F, Lanci A, Mariella J, Viciani E, Quercia S, Castagnetti A
Animals (Basel). 2021; 11(8).
PMID: 34438741
PMC: 8388449.
DOI: 10.3390/ani11082283.
Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome.
Shahi F, Redeker K, Chong J
JAC Antimicrob Resist. 2021; 1(1):dlz015.
PMID: 34222889
PMC: 8210077.
DOI: 10.1093/jacamr/dlz015.
Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment.
Raplee I, Walker L, Xu L, Surathu A, Chockalingam A, Stewart S
Antimicrob Resist Infect Control. 2021; 10(1):36.
PMID: 33588951
PMC: 7885457.
DOI: 10.1186/s13756-021-00903-0.
Characterization of Strains, the Disease Severity, and the Microbial Changes They Induce.
Rohana H, Azrad M, Nitzan O, Adler A, Binyamin D, Koren O
J Clin Med. 2020; 9(12).
PMID: 33353133
PMC: 7766075.
DOI: 10.3390/jcm9124099.
Infant Skin Bacterial Communities Vary by Skin Site and Infant Age across Populations in Mexico and the United States.
Manus M, Kuthyar S, Perroni-Maranon A, la Mora A, Amato K
mSystems. 2020; 5(6).
PMID: 33144313
PMC: 7646528.
DOI: 10.1128/mSystems.00834-20.
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective.
Prokopidis K, Cervo M, Gandham A, Scott D
Nutrients. 2020; 12(8).
PMID: 32751533
PMC: 7468805.
DOI: 10.3390/nu12082285.
Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut: The Role of and Human Milk Oligosaccharides.
Duar R, Henrick B, Casaburi G, Frese S
Front Nutr. 2020; 7:33.
PMID: 32346537
PMC: 7171047.
DOI: 10.3389/fnut.2020.00033.
IRT5 Probiotics Changes Immune Modulatory Protein Expression in the Extraorbital Lacrimal Glands of an Autoimmune Dry Eye Mouse Model.
Choi S, Oh J, Ryu J, Kim H, Im S, Kim K
Invest Ophthalmol Vis Sci. 2020; 61(3):42.
PMID: 32232342
PMC: 7401425.
DOI: 10.1167/iovs.61.3.42.
Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study.
Bau M, Moretti A, Bertoni E, Vazzoler V, Luini C, Agosti M
Pediatr Gastroenterol Hepatol Nutr. 2020; 23(1):35-48.
PMID: 31988874
PMC: 6966223.
DOI: 10.5223/pghn.2020.23.1.35.
Attenuation of immune-mediated bone marrow damage in conventionally housed mice.
Li J, Dubois W, Thovarai V, Wu Z, Feng X, Peat T
Mol Carcinog. 2020; 59(2):237-245.
PMID: 31898340
PMC: 7432962.
DOI: 10.1002/mc.23151.
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants.
DSouza A, Moodley-Govender E, Berla B, Kelkar T, Wang B, Sun X
Clin Infect Dis. 2019; 71(11):2858-2868.
PMID: 31832638
PMC: 7778358.
DOI: 10.1093/cid/ciz1186.